Dosing strategies for gene therapies
The original goal of gene therapy was to deliver a single administration that would maintain therapeutic effectiveness over a patient’s lifetime. This ‘one and done’ model appears to have worked for some gene therapies, with promising follow-up data evidenced. However, in some instances, including gene therapies for hemophilia, a single dose may not be enough, and redosing may be required.
In this article, our gene therapy experts at Health Advances, Parexel’s commercial strategy group, outline considerations for ’one-and-done’ versus redosing therapies.
Related Insights
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Cell & Gene Unscripted: Real-world evidence
Sep 16, 2026
Blog
Cell & Gene Unscripted: Rare and genetic diseases
Sep 16, 2026
Blog
Cell & Gene Unscripted: Rethinking clinical research
Sep 16, 2026
Blog
Cell & Gene Unscripted: Project management
Aug 24, 2026
Blog
Cell & Gene Unscripted: Strategy solutions
Aug 24, 2026
Blog
Cell & Gene Unscripted: Asia-Pacific
Aug 24, 2026
Blog
Cell & Gene Unscripted: Regulatory affairs
Aug 10, 2026
Blog
Cell & Gene Unscripted: Pre-clinical
Aug 10, 2026
Blog
Cell & Gene Unscripted: Neuroscience
Aug 10, 2026
Blog
Are unanchored matching-adjusted indirect comparisons a non-starter in EU Joint Clinical Assessments?
Jul 7, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
Related Insights
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Cell & Gene Unscripted: Real-world evidence
Sep 16, 2026
Blog
Cell & Gene Unscripted: Rare and genetic diseases
Sep 16, 2026
Blog
Cell & Gene Unscripted: Rethinking clinical research
Sep 16, 2026
Blog
Cell & Gene Unscripted: Project management
Aug 24, 2026
Blog
Cell & Gene Unscripted: Strategy solutions
Aug 24, 2026
Blog
Cell & Gene Unscripted: Asia-Pacific
Aug 24, 2026
Blog
Cell & Gene Unscripted: Regulatory affairs
Aug 10, 2026
Blog
Cell & Gene Unscripted: Pre-clinical
Aug 10, 2026
Blog
Cell & Gene Unscripted: Neuroscience
Aug 10, 2026
Blog
Are unanchored matching-adjusted indirect comparisons a non-starter in EU Joint Clinical Assessments?
Jul 7, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026